| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/25/2004 | US6740502 Chelation in presence of protease; bioavailability |
| 05/25/2004 | US6740337 Stability |
| 05/25/2004 | US6740333 Suppository and composition comprising at least one polyethylene glycol |
| 05/25/2004 | US6740327 Use for cosmetic and dermatological indications, reducing and soothing mucosa and skin erythema, inflammation or reaction caused by internal or external factors, wound healing, etc. |
| 05/25/2004 | US6740326 Water-free topical application composition for treatment of nail diseases and nail care consisting of antimycotic agent and lower alkyl ester of lactic acid, malic acid, tartaric acid or citric acid as penetration promoting carrier |
| 05/25/2004 | US6740309 Delivery of compounds for the treatment of migraine through an inhalation route |
| 05/25/2004 | US6740308 Composition comprising condensation aerosol formed by volatilizing antihistamine under conditions effective to produce heated vapor and condensing to form condensation aerosol particles having less than 5% degradation products |
| 05/25/2004 | US6740307 Delivery of β-blockers through an inhalation route |
| 05/25/2004 | CA2267497C Edible, low calorie compositions of a carrier and an active ingredient and methods for preparation thereof |
| 05/25/2004 | CA2185457C Use of nitric oxide-releasing polymers to treat restenosis and related disorders |
| 05/25/2004 | CA2153893C The preparation of colloidal aqueous solutions of active substances of low solubility and a lipid therefor |
| 05/25/2004 | CA2140468C Percutaneous administration tape preparation |
| 05/25/2004 | CA2101871C Transdermic pharmaceutical preparation |
| 05/22/2004 | CA2417634A1 Plastic and elastic protein copolymers |
| 05/21/2004 | WO2004042068A2 Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation |
| 05/21/2004 | WO2004042013A2 Identification of diet-regulated disease-associated genes |
| 05/21/2004 | WO2004041923A2 Chemoenzymatically hydrolysable biologically active compounds |
| 05/21/2004 | WO2004041869A2 Reactive polymers having chemoenzymatically hydrolysable functional groups |
| 05/21/2004 | WO2004041828A1 Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer |
| 05/21/2004 | WO2004041754A2 Calixarene-based guest-host assemblies for guest storage and transfer |
| 05/21/2004 | WO2004041317A1 Self-folding polymer microparticles |
| 05/21/2004 | WO2004041310A1 Preparation of chemically well-defined carbohydrate dendrimer conjugates |
| 05/21/2004 | WO2004041307A2 Compositions and methods for treating cancer using cytotoxic cd44 antibody immunoconjugates and radiotherapy |
| 05/21/2004 | WO2004041297A2 Modified cytokines for use in cancer therapy |
| 05/21/2004 | WO2004041249A1 Microemulsion concentrate for oral administration of water-insoluble anti-cold drug and method for preparing same |
| 05/21/2004 | WO2004041245A2 Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 05/21/2004 | WO2004041243A2 Stable amorphous celecoxib composite and process therefor |
| 05/21/2004 | WO2004041198A2 Heat pasteurized liquids containing glucosamine |
| 05/21/2004 | WO2004041194A2 Inhibition of hiv-1 replication |
| 05/21/2004 | WO2004041188A2 Compositions and methods for transdermal oxybutynin therapy |
| 05/21/2004 | WO2004041187A2 Compositions and methods for transdermal oxybutynin therapy |
| 05/21/2004 | WO2004041172A2 Interferon antagonists useful for the treatment of interferon related diseases |
| 05/21/2004 | WO2004041158A2 Rifalazil compositions and therapeutic regimens |
| 05/21/2004 | WO2004041067A2 Prevention and treatment of synucleinopathic disease |
| 05/21/2004 | WO2004040997A2 Multiple component food product useful for delivering glucosamine and/or nacetyl-d-glucosamine |
| 05/21/2004 | WO2004028272A3 Injectable growth promoting and anthelmintic composition |
| 05/21/2004 | WO2004019800A3 Breath freshening and oral cleansing product |
| 05/21/2004 | WO2004016244A3 Pharmaceutical compositions for buccal delivery of pain relief medications |
| 05/21/2004 | WO2004016243A3 Methods of administering and enhancing absorption of pharmaceutical agents |
| 05/21/2004 | WO2003000485B1 Method and device for producing compression coated tablets |
| 05/21/2004 | WO2002090361A8 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 05/21/2004 | WO2002067952A8 Prophylactic teat treatment |
| 05/21/2004 | WO2002062393A8 Coating for orally administered compositions |
| 05/21/2004 | WO2002061105A8 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 05/21/2004 | CA2718277A1 Compositions and methods for transdermal oxybutynin therapy |
| 05/21/2004 | CA2543376A1 Interferon antagonists useful for the treatment of interferon related diseases |
| 05/21/2004 | CA2504842A1 Self-folding polymer microparticles |
| 05/21/2004 | CA2504021A1 Compositions and methods for transdermal oxybutynin therapy |
| 05/21/2004 | CA2503811A1 Identification of diet-regulated disease-associated genes |
| 05/21/2004 | CA2503561A1 Prevention and treatment of synucleinopathic disease |
| 05/21/2004 | CA2502864A1 Heat pasteurized liquids containing glucosamine |
| 05/21/2004 | CA2484943A1 Stable amorphous celecoxib composite and process therefor |
| 05/20/2004 | US20040098118 Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device |
| 05/20/2004 | US20040097906 Osmotic delivery system with early zero order push power engine |
| 05/20/2004 | US20040097659 Polyethylene glycol containing sugar residue and carboxylic acid side chains; drug delivery and gene transfer carrier; aggregation inhibition; expression efficiency; water solubility |
| 05/20/2004 | US20040097592 Adding nonionic surfactant and antioxidant; preventing decomposition and container adsorption of prostaglandin derivative in ophthalmic solution |
| 05/20/2004 | US20040097586 Anti-tumor compounds |
| 05/20/2004 | US20040097536 Extended release oral dosage composition |
| 05/20/2004 | US20040097533 Useful as potassium channel blockers and antiarrhythmic drugs |
| 05/20/2004 | US20040097514 Sustained release ranolazine formulations |
| 05/20/2004 | US20040097500 Compounds and compositions for delivering active agents |
| 05/20/2004 | US20040097489 2-methyl-thieno-benzodiazepine formulation |
| 05/20/2004 | US20040097472 Complexes of phosphate derivatives |
| 05/20/2004 | US20040097470 Use of alkylphosphocholines in combination with antitumor medications for the treatment of benign and malignant oncoses in humans and mammals |
| 05/20/2004 | US20040097453 Introducing to the subject, or to a target group of cells from the subject, an expressible polynucleotide encoding a eukaryotic heat shock protein for stimulating a therapeutic immune response |
| 05/20/2004 | US20040097419 Organic compounds |
| 05/20/2004 | US20040097403 Linkable sialyl lewis x analogs |
| 05/20/2004 | US20040097399 Medicinal association of a biguanine and a carrier, for example metformin and arginine |
| 05/20/2004 | US20040096651 Pressure-sensitive adhesive sheet for medical use and process for producing the same |
| 05/20/2004 | US20040096566 Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof |
| 05/20/2004 | US20040096522 Synergistic mixtures |
| 05/20/2004 | US20040096521 Topical applying aspirin solutions |
| 05/20/2004 | US20040096514 For treatment of skin contour deficiencies, Gastro-esophageal reflux disease, urinary incontinence, and urinary reflux disease, using the injectable compositions. |
| 05/20/2004 | US20040096513 Systemically minimizing the inflammatory effects of TNF- alpha are disclosed. The compositions include particles of bioactive glass with a particle size less than about 20 mu m, alone or in combination with anti-inflammatory agents and |
| 05/20/2004 | US20040096512 Phospholipid composition and use of same |
| 05/20/2004 | US20040096508 A polymeric solution capable of gelling upon exposure to a critical minimum value of a plurality of environmental stimuli is disclosed. The polymeric solution may be an aqueous solution utilized in vivo and capable of having the gelation |
| 05/20/2004 | US20040096507 Novel hexa-arm polyethylene glycol and its derivatives and the methods of preparation thereof |
| 05/20/2004 | US20040096506 Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 05/20/2004 | US20040096503 Dry-powder film coating composition and method of preparation |
| 05/20/2004 | US20040096502 Pharmaceutical pellets comprising tamsulosin |
| 05/20/2004 | US20040096500 Reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is |
| 05/20/2004 | US20040096496 Sustained release pharmaceutical composition of a cephalosporin antibiotic |
| 05/20/2004 | US20040096494 Composition in the form of lipoglobules which comprises (a) one or more NO-releasing NSAID(s); (b) one or more surfactants and water as well as a composition for pain and inflamation |
| 05/20/2004 | US20040096493 Preparing a therapeutic formulation containing phosphate derivatives of electron transfer agents comprising steps of phosphorylation and P4O10 to form a mixture of at least one mono-electron transfer agent phosphate derivative and at least |
| 05/20/2004 | US20040096491 Adhesive patch |
| 05/20/2004 | US20040096490 Highly flexible transdermal therapeutic system having nicotine as active substance |
| 05/20/2004 | US20040096487 Treating healed wounds including hypertrophic scars so as to prevent scarring or reduce the size and improve the appearance of scars comprises applying to the healed wound or scar a composition comprising a fluid, film-forming carriers |
| 05/20/2004 | US20040096468 An emulsion from about 0.1-70% w/v of a mixture of one or more conjugated diene fatty acids and one or more macromolecules selected from useful as a carrier and delivery vehicle of the macromolecules to humans or animals in need of the |
| 05/20/2004 | US20040096461 Methods of using the conjugate to immunize subjects against bacterial infections. A conjugate molecule of the invention comprises multiple bacterial capsular polysaccharides linked to a carrier protein. The conjugate molecule provides immune |
| 05/20/2004 | US20040096455 Device for transdermally delivering an immunologically active agent, the device comprising: member having a plurality of stratum corneum-piercing microprotrusions and dry coating on said member; said coating, before drying, comprising an |
| 05/20/2004 | US20040096442 Modified anti-egfr antibodies with reduced immunogenicity |
| 05/20/2004 | US20040096437 Pharmaceutical composition comprising arginine deiminasa for inhibiting angio-genesis |
| 05/20/2004 | US20040096429 Method for producing cytotoxic T-cells |
| 05/20/2004 | US20040096426 Compositions and methods for identifying antigens which elicit an immune response |
| 05/20/2004 | US20040096422 Methods for reducing pain and organ dysfunction using bioadhesive, bioresorbable, anti-adhesion compositions made of intermacromolecular complexes of carboxyl-containing polysaccharides, polyethers, polyacids, polyalkylene oxides, |
| 05/20/2004 | US20040096413 Cosmetic composition comprising a complex of cyclodextrin and vitamin F |
| 05/20/2004 | US20040096405 Topical delivery of anti-alopecia agents |
| 05/20/2004 | US20040096401 Methods and compositions for the pulmonary delivery of insulin |
| 05/20/2004 | US20040096400 Methods and compositions for the pulmonary delivery insulin |
| 05/20/2004 | US20040096399 Inhalers containing a solution of an active ingredient in a hydrofluorocarbon propellant and a cosolvent; the internal surfaces consist of stainless steel, anodised aluminium or are lined with an inert organic coating. |